Medicines Co. Stock
Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Medicines Co. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medicines Co. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medicines Co. | - | - | - | - | - | - | - |
| Opko Health Inc. | 0.000% | -3.361% | 15.000% | 0.753% | 5.485% | -26.583% | -63.082% |
| Repligen Corp. | 5.290% | 0.560% | 11.189% | 35.026% | 1.952% | -1.102% | -34.638% |
| China Traditional Chinese Medicine Co Ltd | 0.000% | 0.000% | 0.000% | -5.983% | 0.917% | -37.853% | -47.867% |
Comments
News
Scholar Rock Eyes Sept. 30 FDA Decision for SMA Drug Apitegromab
Key Points
- Interested in Scholar Rock Holding Corporation? Here are five stocks we like better.
- Scholar Rock expects an FDA decision on September 30 for apitegromab, an investigational treatment
Fulcrum Therapeutics Merges With Slate in $245M Migraine Biotech Deal
Key Points
- Interested in Fulcrum Therapeutics, Inc.? Here are five stocks we like better.
- Fulcrum Therapeutics will merge with migraine biotech Slate Medicines in an all-stock transaction
RenovoRx Eyes 2027 TIGeR-PaC Readout as RenovoCath Expands to 21 Centers
Key Points
- Interested in RenovoRx, Inc.? Here are five stocks we like better.
- RenovoRx’s Phase III TIGeR-PaC trial is fully enrolled and had recorded 78 of 86 required events; final events are